Article info
PDFEBM verdict
General medicine
Should patients with atrial fibrillation and stable coronary artery disease receive an oral anticoagulant, an antiplatelet or both?
- Correspondence to Dr Mark T Mills, Department of Cardiology, Sheffield Teaching Hospitals NHS Foundation Trust, Sheffield S5 7AU, UK; marktmills1{at}gmail.com
Citation
Should patients with atrial fibrillation and stable coronary artery disease receive an oral anticoagulant, an antiplatelet or both?
Publication history
- Accepted May 6, 2020
- First published June 3, 2020.
Online issue publication
January 10, 2023
Article Versions
- Previous version (7 January 2022).
- You are viewing the most recent version of this article.
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
© Author(s) (or their employer(s)) 2021. No commercial re-use. See rights and permissions. Published by BMJ.